Results of the "Ocular hypertension treatment study" [Ergebnisse der "Ocular hypertension treatment study" (OHTS)]

被引:0
|
作者
Pfeiffer N. [1 ,2 ]
机构
[1] Augenklinik, Universität, Mainz
[2] Augenklinik, Universität, 55131 Mainz
来源
Der Ophthalmologe | 2005年 / 102卷 / 3期
关键词
Intraocular pressure; Ocular hypertension; Ocular hypertension treatment study; Primary open-angle glaucoma; Risk factors;
D O I
10.1007/s00347-004-1150-x
中图分类号
学科分类号
摘要
Ocular hypertension (OHT) is defined as intraocular pressure (IOP) elevated above normal levels which occurs without detectable damage to the papilla or visual field. It is considered to be the most important risk factor for developing primary open-angle glaucoma (POAG). The .,Ocular hypertension treatment study" (OHTS) addresses the issue of whether lowering IOC before damage to the papilla or visual field occurs can hinder their development and whether OHT can be treated categorically. This randomized, prospective, nonmasked and non-placebo-controlled, multicenter study documents the protective effect of prophylactic lowering of IOC and identifies and explains the risk factors for developing POAG. These include advancing age, reduced corneal thickness, increased pattern standard deviations in white-on-white perimetry, and elevated vertical or horizontal cup to disc ratio. Due to the large individual differences in risk distribution and the very high costs of treating OHT, the question of whether OHT should be treated on principle remains open in the OHTS. This decision must be made on an individual basis after each patient's risk has been assessed. © Springer Medizin Verlag 2005.
引用
收藏
页码:230 / 234
页数:4
相关论文
共 50 条
  • [31] Pre- and Post-POAG Rate of Visual Field Progression in the Ocular Hypertension Treatment (OHTS) Study
    Gordon, Mae E.
    Brandt, James David
    Heuer, Dale K.
    Higginbotham, Eve J.
    Parrish, Richard K., II
    Johnson, Chris A.
    Keltner, John L.
    Huecker, Julia
    Kass, Michael A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [32] Glaucoma Risk Alleles in the Ocular Hypertension Treatment Study
    Scheetz, Todd E.
    Faga, Ben
    Ortega, Lizette
    Roos, Ben R.
    Gordon, Mae O.
    Kass, Michael A.
    Wang, Kai
    Fingert, John H.
    OPHTHALMOLOGY, 2016, 123 (12) : 2527 - 2536
  • [33] Visual Field Progression in the Ocular Hypertension Treatment Study
    Gordon, Mae o.
    Heuer, Dale k.
    Higginbotham, Eve j.
    Parrish, Richard k.
    Liu, Lei
    Brandt, James d.
    Huecker, Julia b.
    Miller, J. phillip
    Perera, Chamila
    Xie, Chris
    Keltner, John l.
    Johnson, Chris a.
    Gardiner, Stuart k.
    Liebmann, Jeffrey m.
    Kass, Michael a.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 271 : 360 - 370
  • [35] Management of patients with ocular hypertension: A cost-effectiveness approach from the ocular hypertension treatment study - Reply
    Kymes, Steven M.
    Kass, Michael A.
    Miller, J. Phillip
    Gordon, Mae O.
    Anderson, Douglas R.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (01) : 192 - 193
  • [36] THE NO TREATMENT APPROACH TO OCULAR HYPERTENSION
    PHELPS, CD
    SURVEY OF OPHTHALMOLOGY, 1980, 25 (03) : 175 - 182
  • [37] Confirmation of visual field abnormalities in the ocular hypertension treatment study
    Keltner, JL
    Johnson, CA
    Quigg, JM
    Cello, KE
    Kass, MA
    Gordon, MO
    ARCHIVES OF OPHTHALMOLOGY, 2000, 118 (09) : 1187 - 1194
  • [38] Classification of visual field abnormalities in the Ocular Hypertension Treatment Study
    Keltner, JL
    Johnson, CA
    Cello, KE
    Edwards, MA
    Bandermann, SE
    Kass, MA
    Gordon, MO
    ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (05) : 643 - 650
  • [39] The ocular hypertension treatment study -: Design and baseline description of the participants
    Gordon, MO
    Kass, MA
    ARCHIVES OF OPHTHALMOLOGY, 1999, 117 (05) : 573 - 583
  • [40] Assessment of the Impact of an Endpoint Committee in the Ocular Hypertension Treatment Study
    Gordon, Mae O.
    Higginbotham, Eve J.
    Heuer, Dale K.
    Parrish, Richard K., II
    Robin, Alan L.
    Morris, Patricia A.
    Dunn, Deborah A.
    Wilson, Bradley S.
    Kass, Michael A.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 199 : 193 - 199